The Future of Inflammatory Biomarkers: Challenges and Clinical Integration
A special issue of Journal of Clinical Medicine (ISSN 2077-0383).
Deadline for manuscript submissions: 31 January 2025 | Viewed by 267
Special Issue Editors
Interests: biomarkers; inflammation; oxidative stress; molecular biology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Current research underscores the complexity and variability of inflammatory responses, necessitating precise biomarkers for improved clinical outcomes. Key problems to be addressed include the identification of specific biomarkers that can reliably differentiate between various inflammatory conditions, the development of standardized protocols for biomarker measurement, and the integration of these biomarkers into routine clinical practice.
The scope of this Special Issue encompasses the discovery of novel inflammatory biomarkers, validation of existing biomarkers, and their clinical application in many diseases. It also includes studies on the molecular mechanisms underlying biomarker expression and their role in disease pathogenesis. Researchers are encouraged to contribute original research articles, reviews, and clinical studies that provide insights into the utility of inflammatory biomarkers, ultimately aiming to enhance patient management and therapeutic strategies. Through this focused collection of research, the Special Issue seeks to bridge gaps in knowledge and foster the translation of biomarker research into clinical practice.
Dr. Sabina Galiniak
Guest Editors
Dr. Marek Biesiadecki
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammatory marker
- inflammation
- biomarker
- cancers
- rheumatoid arthritis
- inflammatory bowel disease
- respiratory diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
